Characterisation of the endothelin receptor mediating contraction of human pulmonary artery using BQ123 and Ro 46-2005
- 1 August 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 260 (2-3) , 221-225
- https://doi.org/10.1016/0014-2999(94)90340-9
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Characterization of three non-peptide endothelin receptor ligands using human cloned ETA and ETB receptorsBritish Journal of Pharmacology, 1994
- Characterization of endothelin receptors and localization of 125I-endothelin-1 binding sites in human umbilical arteryEuropean Journal of Pharmacology, 1993
- In vitro characterization of Ro 46‐2005, a novel synthetic non‐peptide endothelin antagonist of ETA and ETB receptorsFEBS Letters, 1993
- Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonistNature, 1993
- Heterogeniety of endothelin/sarafotoxin receptors mediating contraction of the human isolated saphenous veinEuropean Journal of Pharmacology, 1993
- A novel ETA‐receptor antagonist, FR 139317, inhibits endothelin‐induced contractions of guinea‐pig pulmonary arteries, but not tracheaBritish Journal of Pharmacology, 1993
- Human Endothelin Receptors Characterized Using Reverse Transcriptase-Polymerase Chain Reaction, In Situ Hybridization, and Subtype-Selective Ligands BQ123 and BQ3020: Evidence for Expression of ETB Receptors in Human Vascular Smooth MuscleJournal of Cardiovascular Pharmacology, 1993
- Effects and specific binding sites of endothelin in human lung preparationsPulmonary Pharmacology, 1991
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959